Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Lymphoid 1Head & Neck 1Genitourinary 1Dermatologic 1

Conditions

Urologic Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Neoplasms 1Melanoma 1Lymphoma, Non-Hodgkin 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Adenoid Cystic 1

Interventions

pembrolizumab 50Nivolumab 21Docetaxel 11atezolizumab 7Ipilimumab 7avelumab 6Cyclophosphamide 6Paclitaxel 5Cetuximab 5Carboplatin 5fludarabine 4Radiotherapy 4Gemcitabine 4utomilumab 3spartalizumab 3lenvatinib 3durvalumab 3Trastuzumab 3Specimen Handling 3Interleukin-2 3Cisplatin 3Bevacizumab 3Albumin-Bound Paclitaxel 3zimberelimab 2tremelimumab 2tisotumab vedotin 2tislelizumab 2sargramostim 2obinutuzumab 2epacadostat 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × GSK-3326595 × Genitourinary × Clear all
NCT02783300 2025-03-10

Meteor 1

GlaxoSmithKline

Phase 1 Completed
297 enrolled 76 charts
DermatologicGenitourinaryHead & NeckLymphoidThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Adenoid Cystic, Lymphoma, Non-Hodgkin, Melanoma, Neoplasms, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡